Transition Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference
07 juin 2011 13h01 HE
|
Transition Therapeutics Inc.
TORONTO, June 7, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that Dr. Tony Cruz, Chairman and Chief Executive Officer...
Transition Therapeutics Announces Third Quarter Fiscal 2011 Financial Results
10 mai 2011 16h01 HE
|
Transition Therapeutics Inc.
TORONTO, May 10, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2011 Financial Results on Tuesday, May 10th, at 4:30 P.M. EDT
09 mai 2011 15h30 HE
|
Transition Therapeutics Inc.
TORONTO, May 9, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, May 10, 2011 at 4:30 P.M. EDT to...
Transition Therapeutics Inc.: News Release
22 févr. 2011 11h10 HE
|
Transition Therapeutics Inc.
TORONTO, Feb. 22, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or "Company") (TSX:TTH) (Nasdaq:TTHI) is aware of the significant increase in its share price in TSX and NASDAQ...
Transition Therapeutics Announces Second Quarter Fiscal 2011 Financial Results
07 févr. 2011 16h01 HE
|
Transition Therapeutics Inc.
TORONTO, Feb. 7, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2011 Financial Results on Monday, February 7th, at 4:30 P.M. EST
04 févr. 2011 13h30 HE
|
Transition Therapeutics Inc.
TORONTO, Feb. 4, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Monday, February 7, 2011 at 4:30 P.M. EST...
Transition Therapeutics Announces Modification of the Collaboration Agreement for ELND005
27 déc. 2010 02h01 HE
|
Transition Therapeutics Inc.
TORONTO, Dec. 27, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or "Company") (TSX:TTH) (Nasdaq:TTHI) today announced that the Company and Elan Corporation, plc ("Elan")...
Transition Therapeutics Announces Agreement Amendment
30 nov. 2010 17h01 HE
|
Transition Therapeutics Inc.
TORONTO, Nov. 30, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) announces an amendment to its agreement with Elan Corporation, plc...
Transition Therapeutics Announces First Quarter Fiscal 2011 Financial Results
11 nov. 2010 16h01 HE
|
Transition Therapeutics Inc.
TORONTO, Nov. 11, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2011 Financial Results on Thursday, November 11th, at 4:30 P.M. EST
09 nov. 2010 17h01 HE
|
Transition Therapeutics Inc.
TORONTO, Nov. 9, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Thursday, November 11, 2010 at 4:30 P.M....